Missing DEX Z-code
MolDX contractors deny tests without the registered Z-code.
How we prevent it: We register tests and attach Z-codes to every claim that needs them.
Molecular and genetic testing claims require precise CPT and PLA coding, payer-specific coverage policies and often prior authorization.
Upfront or setup fees
Revenue cycle steps managed end to end
Specialties and lab types we bill for
Of your data and systems stay yours
Molecular and genetic testing claims require precise CPT and PLA coding. Tests may have their own Tier 1 or Tier 2 codes, a proprietary laboratory analysis (PLA) code or no specific code at all.
In MolDX jurisdictions, many tests need a technical assessment and a DEX Z-code on the claim. Commercial payers often send genetic tests through lab benefit managers for prior authorization, and some tests are once-per-lifetime.
We code molecular tests to the most specific available code, attach Z-codes, manage prior authorization and handle the Medicare date-of-service rules for hospital patients.
Also see our medical coding, denial management, eligibility verification and revenue cycle management services.
Molecular codes include gene-specific codes, panels, PLA codes and unlisted codes.
| Code | Description | What we watch for |
|---|---|---|
| 81162 | BRCA1 and BRCA2 full sequence and duplication/deletion analysis | Coverage depends on personal and family history criteria. |
| 81220 | CFTR gene analysis, common variants | Often used for carrier screening. |
| 81225 | CYP2C19 gene analysis, common variants | Pharmacogenomic testing coverage is limited to specific drugs. |
| 81301 | Microsatellite instability analysis | Common in tumor testing. |
| 81445 | Targeted genomic sequence analysis panel, solid organ neoplasm, 5–50 genes | Billed once regardless of the number of genes in range. |
| 81455 | Targeted genomic sequence analysis panel, solid organ or hematolymphoid neoplasm, 51 or more genes | Payers often require prior authorization. |
| 0037U | Targeted genomic sequence analysis, solid organ neoplasm, 324 genes (PLA) | PLA codes identify a specific lab’s test. |
| 81528 | Oncology (colorectal) screening, multitarget stool DNA | Covered as a screening test at set intervals. |
| 87798 | Infectious agent detection by nucleic acid, not otherwise specified, amplified probe | Billed per organism; check payer limits for panels. |
| 81479 | Unlisted molecular pathology procedure | Requires documentation of the test and often a Z-code. |
Code descriptions are summarized. CPT® is a registered trademark of the American Medical Association. Coverage and payment rules vary by payer and change every year; we code to the current code set and your payers’ policies.
Reference laboratoryWhen a test is sent to another lab for performance.
Distinct serviceFor separate tests NCCI pairs together.
ABN on fileFor tests that may not be covered.
Expected denial, no ABNReports that denial is expected without an ABN.
The denial reasons we see most often in molecular lab billing, with the claim adjustment reason code (CARC) payers usually attach, and what we do so they don't happen again.
MolDX contractors deny tests without the registered Z-code.
How we prevent it: We register tests and attach Z-codes to every claim that needs them.
Payers limit coverage to specific clinical criteria and history.
How we prevent it: We check criteria and document the indication before testing.
Genetic testing is often managed by lab benefit managers.
How we prevent it: We submit authorization with clinical history and family history.
Germline tests may only be covered once.
How we prevent it: We check prior testing before billing.
Tests for hospital patients may need to be billed to the hospital.
How we prevent it: We apply the lab date-of-service rules and exceptions.
From the first eligibility check to the final patient payment, one dedicated team handles every step and reports back to you.
We verify coverage, benefits, copays and deductibles before the visit. For molecular labs, that includes prior authorization and coverage criteria for each test.
Our coders review documentation and assign CPT, HCPCS and ICD-10-CM codes to the highest supported specificity. Tests are coded to the most specific CPT, PLA or Tier 2 code, with Z-codes added.
Every claim is checked against NCCI edits, payer policies and modifier rules before it goes out electronically, so it is paid on the first pass.
We post ERAs and EOBs, compare payments to your contracted rates and flag underpayments for appeal.
Every denial is worked: corrected, appealed or escalated, with root causes fed back to the front end. Coverage and authorization denials are appealed with clinical history and test details.
You get clear monthly reports on collections, denials and A/R aging, and patients get easy-to-read statements and answers to billing questions.
Rules that change how molecular lab claims must be coded, documented and submitted.
MolDX: many Medicare contractors require a technical assessment and DEX Z-code for molecular tests.
PLA codes: identify a specific lab’s test and should be used instead of general codes when they apply.
Date of service exception: certain molecular tests for hospital outpatients can be billed by the lab directly.
Germline versus somatic: coverage rules differ for inherited and tumor testing.
Send us a sample of your molecular lab denials and A/R. We'll show you where revenue is slipping and how we'd fix it, with no obligation and no upfront fees.